Ignite Creation Date:
2024-05-06 @ 3:56 AM
Last Modification Date:
2024-10-26 @ 11:41 AM
Study NCT ID:
NCT02414139
Status:
COMPLETED
Last Update Posted:
2024-03-20
First Post:
2015-03-31
Brief Title:
Study of Oral cMET Inhibitor INC280 in Patients With EGFR Wild-type wt Advanced Non-small Cell Lung Cancer NSCLC Geometry Mono-1
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Organization Data
Organization:
Novartis
Class:
INDUSTRY
Study ID:
CINC280A2201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Novartis Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None